Cancer Therapeutics Drugs Market Share

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific industry is estimated to dominate majority revenue share by 2036, owing to increasing awareness, rise in disposable incomes, high incidence rate of cancer, and need to develop innovative cancer treatment solutions in the region.

Furthermore, in 2021, the cancer drugs market in North America is evaluated to occupy the largest share in terms of revenue, owing to the growing investment of governmental and non-governmental agencies in cancer research, accompanied by the presence of leading healthcare service providers in the region. Along with this, the North America also leads in terms of ongoing clinical trials, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the cancer drugs on account of its proven success in terms of drug development and a high prevalence of cancer in the region. As per the analysis of National Centre for Biotechnology Information, greater cancer prevalence in the European Union is due to High GDP per Capita, high animal fat intake which results in high cholesterol levels and are important factors in cancer progression.